Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Optomed

1.73 EUR+14.15 %6/11 17:29
5,672 following

OPTOMED

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Short Selling
Investor views
Compare
+14.15 %
+24.53 %
+8.01 %
+5.89 %
-54.22 %
-56.80 %
-36.66 %
-81.98 %
-62.31 %

Optomed operates in the medical technology sector. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that are resold under different brands. Operations are held on a global level, with the largest presence in the Nordic market. Customers consist of research institutes and hospitals. The company has its headquarters in Oulu.

Read more
Market cap
37.1M EUR
Turnover
660.82K EUR
P/E (adj.) (26e)
-13.64
EV/EBIT (adj.) (26e)
-9.89
P/B (26e)
1.74
EV/S (26e)
1.83
Dividend yield-% (26e)
-
Coverage
Recommendation
Accumulate
Target price
2.00 EUR
Updated
2026-08-17
Disclaimer
Juha Kinnunen
Juha Kinnunen

Analyst

Latest research

Latest analysis report

Released: 2026-08-17

Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types

Forum discussions
A few bears have been visiting this thread regularly. I’d love to hear a status update from them as well, as they’ve pointed out some quite sensible risks. Has the situation changed in their view, and if so, how? Showing some backbone would mean staying bearish even when the reports...
17 hours ago
by Perttu Hämäläinen
33
A neat earnings improvement, and the trend just seems to keep getting better quarter after quarter. Costs have been reduced by a whopping €0.7M on a quarterly basis, and apparently permanently. At this rate, the cash runway should be enough to reach break-even, and once the profits...
20 hours ago
by Sheikki
29
This really looks like a total no-brainer right now, reaching break-even already at this point is just insane. Being able to forecast profits for next year already feels wild, but that’s often how these things tend to go. Buying every month up to €10/share is just a can’t-lose strategy...
18 hours ago
by Velkku
22
Regarding the funds: over the past six months, three major funds (Säästöpankki (Small Cap), Osuuspankki (Small Cap), Danske) have dumped around 1.2 million shares (6% of the company’s total shares). One can only imagine the impact this has on the share price performance of an illiquid...
18 hours ago
by Dr.Feelgood
21
I might not be a bear, but perhaps a harbinger of bad news when needed? With the current tailwind, things look good, but the moat is still very small (in a potential market of tens of thousands of cameras, they only have a few hundred), and all the eggs are in one basket (AEYE). ...
16 hours ago
by Dr.Feelgood
16
Bought a few shares on Friday, so I’m not a bear, but the ownership structure makes me wonder. This is mostly owned by funds and lacks an actual anchor/principal owner. Why hasn’t Optomed attracted anyone with a more “proven track record in making money”? Management and board ownership...
1 hour ago
by Karhu Hylje
9
The situation is pretty much exactly the same for quite a few other fund management companies as well.
18 hours ago
by Due Diligence
6
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
18/2
2027

Annual report '26

4/5
2027

Interim report Q1'27

11/5
2027

General meeting '27

Optomed Q3'26: Earnings improved and costs are decreasing36:52
Video2026-11-06 15:59
by Juha Kinnunen

Optomed Q3'26: Earnings improved and costs are decreasing

Optomed's earnings developed better than expected in the quarter, as costs decreased and Optomed focused even more closely on the growth potential of better profitability. CEO Juho Himberg is interviewed by analyst Juha Kinnunen.

Optomed
Regulatory press release2026-11-06 08:00

Optomed Plc: Interim report January - September 2026

Optomed
Optomed Q3'26 förhandskommentar: En positiv resultatvändning i sikte
Analyst Comment2026-11-03 06:45
by Juha Kinnunen

Optomed Q3'26 förhandskommentar: En positiv resultatvändning i sikte

En utrustningsbeställning på 1,8 miljoner euro från USA vänder enligt vår bedömning EBITDA till att bli positiv.

Optomed

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-10-07 13:00

Optomed Oyj: Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings

Optomed
Regulatory press release2026-09-28 15:17

Optomed Oyj - Managers' Transactions - Piila

Optomed
Regulatory press release2026-09-28 15:15

Optomed Oyj - Managers' Transactions - Piila

Optomed
Regulatory press release2026-09-28 15:15

Optomed Oyj - Managers' Transactions - Piila

Optomed
Regulatory press release2026-09-28 15:15

Optomed Oyj - Managers' Transactions - Piila

Optomed
Regulatory press release2026-09-28 15:12

Optomed Oyj - Managers' Transactions - Myllylä

Optomed
Regulatory press release2026-09-28 15:10

Optomed Oyj - Managers' Transactions - Myllylä

Optomed
Regulatory press release2026-09-28 15:10

Optomed Oyj - Managers' Transactions - Myllylä

Optomed
Regulatory press release2026-09-28 15:10

Optomed Oyj - Managers' Transactions - Myllylä

Optomed
Regulatory press release2026-09-28 15:07

Optomed Oyj - Managers' Transactions - Knuutti

Optomed
Regulatory press release2026-09-28 15:05

Optomed Oyj - Managers' Transactions - Knuutti

Optomed
Regulatory press release2026-09-28 15:05

Optomed Oyj - Managers' Transactions - Knuutti

Optomed
Regulatory press release2026-09-28 15:05

Optomed Oyj - Managers' Transactions - Knuutti

Optomed
Regulatory press release2026-09-28 15:01

Optomed Oyj - Managers' Transactions - Himberg

Optomed
Regulatory press release2026-09-28 15:00

Optomed Oyj - Managers' Transactions - Himberg

Optomed
Regulatory press release2026-09-28 15:00

Optomed Oyj - Managers' Transactions - Himberg

Optomed
Regulatory press release2026-09-28 15:00

Optomed Oyj - Managers' Transactions - Himberg

Optomed